| 000 | 01595 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516051658.0 | ||
| 264 | 0 | _c20110913 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a0172-6390 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTaskoparan, Muharrem | |
| 245 | 0 | 0 |
_aEarly effect of peginterferon alpha-2b plus ribavirin treatment on blood pressure and insulin resistance in patients with chronic hepatitis C. _h[electronic resource] |
| 260 |
_bHepato-gastroenterology _c |
||
| 300 |
_a875-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aBlood Pressure Monitoring, Ambulatory |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xadministration & dosage |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aRibavirin _xadministration & dosage |
| 700 | 1 | _aSerin, Ender | |
| 700 | 1 | _aGokturk, Huseyin Savas | |
| 700 | 1 | _aIcer, Mustafa Okan | |
| 700 | 1 | _aAbaci, Kutlu | |
| 700 | 1 | _aOzer, Birol | |
| 700 | 1 | _aZumrutdal, Aysegul | |
| 700 | 1 | _aYilmaz, Ugur | |
| 773 | 0 |
_tHepato-gastroenterology _gvol. 58 _gno. 107-108 _gp. 875-9 |
|
| 999 |
_c21075013 _d21075013 |
||